RAD50 and ovarian cancer: To verify whether Rad50‐mediated activation of NF‐κB pathway is CARD9 dependent, we knocked down CARD9 in Rad50‐overexpressed ovarian cancer cell lines and found that knockdown of CARD9 significantly reversed Rad50‐induced migration activities (Figure S5B).